Clinical Trial Update: Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy and safety of KAF156 in combination with LUM-SDF for uncomplicated Plasmodium falciparum malaria in adults and children; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uncomplicated Plasmodium Falciparum Malaria

Drugs mentioned

• KAF156 (ganaplacide)
• LUM-SDF

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Uncomplicated Plasmodium Falciparum Malaria | Phase 2 | Status: COMPLETED | Results posted: 2022-02-10